Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 10, 2007, Pages 1975-1986

  Chew, Choy Hoong ^a   Chew, Guat Siew ^a   Najimudin, Nazalan ^a   Tengku Muhammad, Tengku Sifzizul ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Acute phase response; CCAAT enhancer binding proteins (C EBP); Gene regulation; Interleukin 6; Peroxisome proliferator activated receptor alpha (PPAR )

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN BINDING;

BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; INTERLEUKIN-6; PPAR ALPHA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN ISOFORMS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 34548363843     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.05.015     Document Type: Article

References (53)

1. Agrawal A., Cha-Molstad H., Samols D., and Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein β (C/EBPβ) and Rel p50. J. Immunol. 166 (2001) 2378-2384
2. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9 (1990) 1897-1906
3. Andus T., Geiger T., Hirano T., Northoff H., Ganter U., Bauer J., et al. Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-β2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221 (1987) 18-22
4. Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J.P., et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator activated receptor and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46 (1997) 1319-1327
5. Bannach F.G., Gutierrez-Fernandez A., Parmer R.J., and Miles L.A. Interleukin-6-induced plasminogen gene expression in murine hepatocytes is mediated by transcription factor CCAAT/enhancer binding protein β (C/EBPβ). J. Thromb. Haemost. 2 (2004) 2205-2212
6. Baumann H., and Gauldie J. The acute phase response. Immunol. Today 15 (1994) 74-80
7. Beier K., Volkl A., and Fahimi D. TNFα down-regulates the peroxisome proliferator activated receptor α and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett. 412 (1997) 385-387
8. Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., and Feingold K.R. The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem. 275 (2000) 16390-16391
9. Bonar E., Dubin A., Bierczynska-Krzysik A., Noga M., Silberring J., Stalinska K., et al. Identification of major cellular proteins synthesised in response to interleukin-1 and interleukin-6 in human hepatoma HepG2 cells. Cytokines 33 (2006) 111-117
10. Braissant O., and Wahli W. Differential expression of peroxisome proliferator activated receptor-α, -β and -γ during rat embryonic development. Endocrinology 139 (1998) 2748-2754
11. Buck M., Zhang L., Halasz N.A., Hunter T., and Chojkier M. Nuclear export of phosphorylated C/EBPβ mediates the inhibition of albumin expression by TNF-α. EMBO J. 20 (2001) 6712-6723
12. Burkart A.D., Mukherjee A., Sterneck E., Johnson P.F., and Mayo K.E. Repression of the inhibin α-subunit gene by the transcription factor CCAAT/enhancer-binding protein β. Endocrinology 146 (2005) 1909-1921
13. Cantwell C.A., Sterneck E., and Johnson P.F. Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by STAT3 and Sp1. Mol. Cell. Biol. 18 (1998) 2108-2177
14. Cao Z., Umek R.M., and McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5 (1991) 1538-1552
15. Castell J.V., Gomez-Lechon M.J., David M., Andus T., Geiger T., Trullenque R., et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242 (1989) 237-239
16. Chew C.H., Samian M.R., Najimudin N., and Tengku-Muhammad T.S. Molecular characterisation of six alternatively spliced variants and a novel promoter in human peroxisome proliferator-activated receptor α. Biochem. Biophys. Res. Commun. 305 (2003) 235-243
17. Di-Poi N., Desvergne B., Michalik L., and Wahli W. Transcription repression of peroxisome proliferator activated receptor β/δ in murine keratinocytes by CCAAT/Enhancer binding proteins. J. Biol. Chem. 280 (2005) 38700-38710
18. Eaton E.M., and Sealy L. Modification of CCAAT/enhancer-binding protein-β by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278 (2003) 33416-33421
19. El-Saadany, M. A., Rawel, H. M., Raila, J., El-Dashloty, M. S., & Schweigert, F. J. (2007). Antioxidants modulate the IL-6 induced inhibition of negative acute-phase protein secretion in HepG2 cells. Cell Biochem. Funct., doi:10.1002/cbf.1405.
20. Fang C., Yoon S., Tindberg N., Jarvelainen H.A., Lindros K.O., and Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol. 67 (2004) 1389-1397
21. Feingold K., Kim M.S., Shigenaga J., Moser A., and Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute phase response. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E201-E207
22. Foka P., Irvine S.A., Kockar F., and Ramji D.P. Interleukin-6 represses the transcription of CCAAT/enhancer binding protein α gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. Nucleic Acids Res. 31 (2003) 6722-6732
23. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with peroxisome proliferator-activated receptor α activator fenofibrate. J. Biol. Chem. 279 (2004) 16154-16160
24. Gervois P., Vu-Dac N., Kleemann R., Kockx M., Dubois G., Laine B., et al. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor α agonists via inhibition of CCAAT box/enhancer-binding protein β. J. Biol. Chem. 276 (2001) 33471-33477
25. Granger R.L., Hughes T.R., and Ramji D.P. Stimulus- and cell-type-specific regulation of CCAAT/enhancer binding protein isoforms in glomerular mesangial cells by lipopolysaccharide and cytokines. Biochim. Biophys. Acta 1510 (2000) 171-179
26. Greenwel P., Tanaka S., Penkov D., Zhang W., Olive M., Moll J., et al. Tumor necrosis factor-α inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol. Cell Biol. 20 (2000) 912-918
27. Gruys E., Toussaint M.J.M., Niewold T.A., and Koopmans S.J. Acute phase response and acute phase proteins. J. Zhejiang Univ. Sci. 6B (2005) 1045-1056
28. Hoang T., Haman A., Goncalves O., Wong G.G., and Clark S.C. Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72 (1988) 823-826
29. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
30. Jover R., Bort R., Gomez-Lechon M.J., and Castell J.V. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: Molecular mechanism and transcription factors involved. FASEB J. 16 (2002) 1799-1801
31. Kinoshita S., Akira S., and Kishimoto T. A member of the C/EBP family, NF-IL6β, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1473-1476
32. Kleemann R., Gervois P.P., Verschuren L., Staels B., Princen H.M., and Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation. Blood 101 (2003) 545-551
33. Kockx M., Gervois P.P., Poulain P., Derudas B., Peters J.M., Gonzalez F.J., et al. Fibrates suppress fibrinogen gene expression in rodents via activation of the PPARα. Blood 93 (2003) 2991-2998
34. Kudo M., Sugawara A., Uruno A., Takeuchi K., and Ito T. Transcription suppression of peroxisome proliferator-activated receptor γ2 gene expression by tumor necrosis factor-α via an inhibition of CCAAT/enhancer-binding protein δ during the early stage of adipocyte differentiation. Endocrinology 145 (2004) 4948-4956
35. Landschulz W.H., Johnson P.F., and McKnight S.L. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240 (1988) 1759-1764
36. Martinez-Jimenez C.P., Castell J.V., Gomez-Lechon M.J., and Jover R. Transcriptional regulation of the human hepatic CYP3A4: Identification of a new distal enhancer region responsive to C/EBPβ isoforms (liver activating protein and liver inhibitory protein). Mol. Pharmacol. 67 (2005) 2088-2101
37. McKnight S.L., Lane M.D., and Gluecksohn-Walsh S. Is CCAAT/enhancer binding protein a central regulator of energy metabolism?. Genes Dev. 3 (1989) 2021-2024
38. Okazaki K., Li J., Yu H., Fukui N., and Sandell L.J. CCAAT/enhancer-binding proteins β and δ mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1β. J. Biol. Chem. 277 (2002) 31526-31533
39. Ossipow V., Descombes P., and Schibler U. CCAAT/enhancer binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8219-8223
40. Panzenboeck U., Kratzer I., Sovic A., Wintersperger A., Bernhart E., Hammer A., et al. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. Int. J. Biochem. Cell Biol. 38 (2006) 1314-1329
41. Pineda-Torra I., Jamshidi Y., Flavell D.M., Fruchart J.C., and Staels B. Characterization of the human PPARα promoter: Identification of a functional nuclear receptor response element. Mol. Endocrinol. 16 (2002) 1013-1028
42. Poli V., Mancini F.P., and Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63 (1990) 643-653
43. Qiao L., Maclean P.S., Schaack J., Orlicky D.J., Darimont C., Pagliassotti M., et al. C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54 (2005) 1744-1754
44. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem. J. 365 (2002) 561-575
45. Ramji D.P., Vitelli A., Tronche F., Cortese R., and Ciliberto G. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBPδ/NF-IL6β, are induced by IL-6 to promote acute-phase gene transcription via different mechanisms. Nucleic Acids Res. 21 (1993) 289-294
46. Ritchie D.G., and Fuller G.M. Hepatocyte-stimulating factor: A monocyte-derived acute phase regulatory protein. Ann. N.Y. Acad. Sci. 408 (1983) 490-502
47. Sehgal P.B., Grieninger G., and Tosato G. Regulation of the acute phase and immune responses: Interleukin-6. Ann. N.Y. Acad. Sci. 557 (1989) 1-583
48. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393 (1998) 790-793
49. Wang J.M., Ko C.Y., Chen L.C., Wang W.L., and Chang W.C. Functional role of NF-IL6β and its SUMOylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res. 34 (2006) 217-231
50. Wei E., Lehner R., and Vance D.E. C/EBPα activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes. Biochem. J. 388 (2005) 959-966
51. Wegrzyn P., Jura J., Kupiec T., Piekoszewski W., Wladyka B., Zarebski A., et al. A search for genes modulated by interleukin-6 or with interleukin-1β in HepG2 cells using defferential display analysis. Biochim. Biophys. Acta 1762 (2006) 319-328
52. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., and Hache R.J. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22 (2003) 2135-2145
53. Yang S.H., and Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell. 13 (2004) 611-617